Ornithine decarboxylase as an enzyme target for therapy
- 1 January 1992
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 54 (2), 195-215
- https://doi.org/10.1016/0163-7258(92)90032-u
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Effects of DL-α-difluoromethylornithine, 4-deoxypyridoxine and methylglyoxal bis(guanylhydrazone) on allograft prolongationLife Sciences, 1991
- Novel Therapy for the Treatment of Human CarcinoidAnnals of Surgery, 1991
- Modulation of the NMDA receptor by polyaminesLife Sciences, 1991
- Polyamine depletion and growth inhibition ofCryptococcus neoformans by α-difluoromethylornithine and cyclohexylamineMycopathologia, 1990
- Human ornithine decarboxylase-encoding loci: nucleotide sequence of the expressed gene and characterization of a pseudogeneGene, 1990
- Treatment of Recurrent Gliomas with 1,3-Bis(2-Chloroethyl)-1-Nitrosourea and A-DifluoromethylornithineNeurosurgery, 1989
- Complete Amino Acid Sequence of Human Ornithine Decarboxylase Deduced from Complementary DNADNA, 1987
- Ornithine Decarboxylase as a Biologic Marker in Familial Colonic PolyposisNew England Journal of Medicine, 1984
- Blood brain barrier breakdown in brain edema following cold injury is mediated by microvascular polyaminesBiochemical and Biophysical Research Communications, 1983
- Anti-proliferative properties of DL-α-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylaseBiochemical and Biophysical Research Communications, 1978